Martynov M Yu, Zhuravleva M V, Vasyukova N S, Kuznetsova E V, Kameneva T R
Pirogov Russian National Research Medical University, Moscow, Russia.
Federal Center of Brain Research and Neurotechnologies, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(1):16-27. doi: 10.17116/jnevro202312301116.
We reviewed the role of oxidative stress (OS) in the pathogenesis of ischemic (IS) and hemorrhagic stroke (HS). OS plays a major role in programmed cell death, increased permeability of the blood-brain barrier, astroglial and microglial activation, and local inflammatory response. We also reviewed the current state of neuro- and cytoprotection studies and their translation in clinical practice. With respect to experimental and clinical data the efficacy of long term administration of multimodal cytoprotective drug with antioxidant effect - ethylmethylhydroxypyridine succinate (Mexidol) is discussed during the acute and early recovery period after stroke.
我们回顾了氧化应激(OS)在缺血性卒中(IS)和出血性卒中(HS)发病机制中的作用。氧化应激在程序性细胞死亡、血脑屏障通透性增加、星形胶质细胞和小胶质细胞激活以及局部炎症反应中起主要作用。我们还回顾了神经保护和细胞保护研究的现状及其在临床实践中的转化应用。根据实验和临床数据,讨论了在卒中急性和早期恢复阶段长期给予具有抗氧化作用的多模式细胞保护药物——丁基羟基吡啶甲磺酸盐(美西多宁)的疗效。